Abiopharma

Janux - Investor Relations - Janux Announces Encouraging Efficacy and Safety Profile from Ongoing Phase 1 Clinical Trial for JANX007 in mCRPC

Announcement relating to convening of Scheme Meeting and Extraordinary General Meeting

Xtant Medical Completes Sale of its Coflex® Assets and Paradigm OUS Businesses to Companion Spine

Alector to Participate in the Bank of America CNS Therapeutics Conference

Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025

Karyopharm Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Solid Biosciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Biomea Fusion, Inc. Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

MindMed Announces New Employee Inducement Grants